The FDA seem to be keen to get some drugs out into the market before the jury has reached a conclusion.
Aducanumab has just been approved for alzheimers as an example.
https://www.statnews.com/2021/06/07/fda-aducanumab-approval-paves-way-momentous-alzheimers-breakthroughs/
https://www.fiercepharma.com/pharma/biogen-fda-aducanumab-decision
Good data for Paxalisib will likely have a very receptive audience at the FDA.
The FDA seem to be keen to get some drugs out into the market...
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)